The North America Clinical Nutrition Market would witness market growth of 6.2% CAGR during the forecast period (2020-2026).
Nutrition and diet are an important part of many health problems. A person is helped to preserve his health and wellbeing with a healthy diet and healthy intakes. Clinical nutrition is a form of nutrition for patients receiving medical care. Clinical nutrition is structured to preserve energy balance and provide essential nutrients such as calories, vitamins, and minerals. It also includes studies of nutrients important for the human body and the way the body is affected by nutrients.
Treatments for cancer can impair taste, smell, appetite, and ability to consume adequate food or absorb food nutrients. This can lead to malnutrition caused by a lack of important nutrients. The risk of malnutrition can rise with alcohol abuse and obesity. Malnutrition may contribute to fatigue, tiredness, and inability to fight illness or to end treatment of cancer. If cancer grows or spreads, malnutrition may become worse. This stresses the critical importance of clinical nutrition especially for treatment, infection control, and strength.
Neurological problems are also concerned with swallowing and starvation. In fact, the possibility of micronutrient loss and dehydration is enhanced for patients with neurological disorders. In comparison, the pathogenesis of neurological disorders may require dietary factors. The multiple causes of malnutrition are known for oropharyngeal dysphagia, impaired consciously, perception deficits, cognitive dysfunction, and increased need in neurological patients.
Based on Route of Administration, the market is segmented into Oral, Enteral and Parenteral. Based on Application, the market is segmented into Cancer, Neurological Diseases, Gastrointestinal Disorders, Metabolic Disorders and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.
Scope of the Study
Market Segmentation:
By Route of Administration

  • Oral
  • Enteral and
  • Parenteral


By Application

  • Cancer
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Metabolic Disorders and
  • Other Applications


By Country

  • US
  • Canada
  • Mexico
  • Rest of North America


Companies Profiled

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Pfizer, Inc.
  • Nestle S.A.
  • Lonza Group AG
  • BASF SE
  • Ajinomoto Co., Inc.
  • Perrigo Company PLC
  • Hero Nutritionals, Inc.


Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free